Matches in Wikidata for { <http://www.wikidata.org/entity/Q104503423> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q104503423 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 19ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104503423 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q104503423 description "scientific article published on 19 December 2020" @default.
- Q104503423 description "wetenschappelijk artikel" @default.
- Q104503423 description "наукова стаття, опублікована 19 грудня 2020" @default.
- Q104503423 name "Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'" @default.
- Q104503423 name "Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'" @default.
- Q104503423 name "Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'" @default.
- Q104503423 type Item @default.
- Q104503423 label "Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'" @default.
- Q104503423 label "Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'" @default.
- Q104503423 label "Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'" @default.
- Q104503423 prefLabel "Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'" @default.
- Q104503423 prefLabel "Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'" @default.
- Q104503423 prefLabel "Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'" @default.
- Q104503423 P1433 Q104503423-1EBE9555-6DA0-40C6-925E-FEA1AFFF018F @default.
- Q104503423 P1476 Q104503423-BBFC814F-3E0E-4F91-9271-5BAD89B43020 @default.
- Q104503423 P2093 Q104503423-307433D2-FB52-4022-8384-61CD5381C5CB @default.
- Q104503423 P2093 Q104503423-B6827387-24C8-4476-907C-5F490D0186E6 @default.
- Q104503423 P2093 Q104503423-FEC45999-9D52-4D08-8C4A-78C6C7A10DE6 @default.
- Q104503423 P31 Q104503423-A828948E-8057-47D5-B934-56E5F557511F @default.
- Q104503423 P356 Q104503423-0569517D-D081-484C-9B86-A1201954D725 @default.
- Q104503423 P577 Q104503423-9DA2B69E-06CF-4F5D-99C5-12AF0F5E16FF @default.
- Q104503423 P698 Q104503423-5DC61135-71E2-4CD4-B8D5-C85CA33077DA @default.
- Q104503423 P356 EJHF.2074 @default.
- Q104503423 P698 33340199 @default.
- Q104503423 P1433 Q5017954 @default.
- Q104503423 P1476 "Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'" @default.
- Q104503423 P2093 "Marla B Sultan" @default.
- Q104503423 P2093 "Ronald Witteles" @default.
- Q104503423 P2093 "Thibaud Damy" @default.
- Q104503423 P31 Q13442814 @default.
- Q104503423 P356 "10.1002/EJHF.2074" @default.
- Q104503423 P577 "2020-12-19T00:00:00Z" @default.
- Q104503423 P698 "33340199" @default.